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Introduction
The identifi  cation and study of tumor suppressor genes has 
provided insight into the normal mechanisms of cell prolifera-
tion control (Sherr, 2004). Most tumor suppressors function 
intracellularly to control the cell division cycle; however, the 
interface between a cell and its environment also plays a critical 
role in tumor development and metastasis. The product of the 
neurofi  bromatosis type 2 (NF2) tumor suppressor gene, Merlin, 
localizes to and appears to act at this interface (McClatchey 
and Giovannini, 2005). Loss of NF2 function is associated 
with the development of multiple cancers in humans and mice 
(McClatchey et al., 1998; Giovannini et al., 2000; Baser et al., 
2002). In humans, NF2 mutations are associated with familial 
and sporadic nervous system tumors and with other sporadic 
cancers such as mesothelioma, whereas heterozygous Nf2 mutant 
mice develop bone, liver, and other tumors that are highly meta-
static. Treatment strategies for NF2 are currently limited given 
the often intractable location and multiplicity of tumors, to-
gether with their tendency to recur. Surgical approaches are the 
current standard therapy and pharmacological treatments are 
not available.
Merlin is closely related to the ERM (Ezrin/Radixin/
Moesin) proteins that are thought to organize cortical membrane 
domains that interface with the extracellular environment, via 
linking membrane-associated proteins to the actin cytoskeleton 
(Bretscher et al., 2002; Lallemand et al., 2003; McClatchey, 
2003; Ramesh, 2004). Although Merlin can functionally and 
physically interact with several proteins, including p21-activated 
kinase (Kissil et al., 2003; Hirokawa et al., 2004), CD44 
(Morrison et al., 2001) and the two PDZ domain  –containing 
adaptors EBP50/NHE-RF1 and E3KARP/NHE-RF2 (Murthy 
et al., 1998; Nguyen et al., 2001), the mechanism whereby 
Merlin controls cell proliferation remains poorly understood 
(McClatchey and Giovannini, 2005).
We have recently found that a signature of Nf2 defi  ciency 
in several types of primary cells, including both mesenchymal 
and epithelial cells, is a failure to undergo contact-dependent 
inhibition of proliferation and to establish stable cadherin-mediated 
adherens junctions (AJs) between cells (Lallemand et al., 2003). 
Merlin is regulated by cell–cell contact (Shaw et al., 1998), local-
izes to AJs, and physically associates with AJ components. 
Although core cadherin–catenin complexes are present in the 
membrane of Nf2
−/− cells, stable AJ structures are not maintained. 
Defective AJs and loss of contact-dependent inhibition of prolif-
eration may explain the tumorigenic and metastatic consequences 
of Nf2 defi  ciency. However, the nature of the mitogenic signals 
that drive proliferation of Nf2
−/− cells with defective AJs is not 
known; indeed, the general mechanism of contact-mediated inhi-
bition of proliferation is not well understood.
Here we present novel mechanistic insight into a critical 
role for the NF2 tumor suppressor, Merlin, in coordinating the 
processes of AJ stabilization with contact-dependent inhibition 
of epidermal growth factor receptor (EGFR) activity. In the 
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absence of Merlin, confl  uent cells are unable to silence mitogenic 
signaling from the EGFR, and their continuous proliferation is 
blocked by specifi  c pharmacological inhibitors of the EGFR. 
Upon cell–cell contact, Merlin associates with EGFR via NHE-
RF1 and prevents both ligand-induced EGFR  internalization 
and the association of EGFR with its canonical effectors, pre-
cluding downstream signaling. Our data are consistent with 
a model whereby upon cell contact Merlin restrains EGFR into 
a membrane compartment from which it can neither signal nor be 
internalized. These studies reveal a novel mechanism of tumor 
suppressor function, linking the function of Merlin to that of 
a well-known oncogene and suggesting a possible therapeutic 
strategy for NF2 mutant tumors.
Results
Cell density–dependent regulation of EGFR 
by Merlin
Our previous studies suggest that due to their inability to es-
tablish stable AJs, Nf2
−/− cells continue to proliferate after reach-
ing confl  uence. However, these studies do not reveal the source 
of mitogenic signals that drive the continued proliferation of 
confl  uent Nf2
−/− cells—in essence the mechanism whereby Nf2-
  expressing cells normally undergo contact-dependent inhibition 
of proliferation. We could not detect altered β-catenin activity, 
nuclear localization, or changes in specifi  c cadherin expression 
in these cells, suggesting that activated β-catenin does not drive 
the overproliferation of confl  uent Nf2
−/− cells (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200703010/DC1; not 
depicted); in fact, normal levels of cadherin-associated β-catenin 
are present in the membranes of confl  uent Nf2
−/− cells (Lallemand 
et al., 2003). Instead, confl  uent Nf2
−/− cells exhibit sustained 
activation of signaling molecules that are not known β-catenin 
targets (Fig. 1 E).
Alternatively, accumulating evidence suggests that cadherin-
dependent cell adhesion can control mitogenic signaling by nega-
tively regulating receptor tyrosine kinases (RTKs) at the plasma 
membrane (Takahashi and Suzuki, 1996; Grazia Lampugnani 
et al., 2003; Qian et al., 2004). To determine whether Merlin 
function is important for contact-dependent inhibition of RTK 
signaling, we compared the profi  le of protein tyrosine phos-
phorylation in wild-type and Nf2
−/− mouse embryo fi  broblasts 
(MEFs) as they progress to high cell density with an increasing 
area of cell–cell contact in the presence of serum (see Fig. S2 A 
for a defi  nition of confl  uence; available at http://www.jcb.org/
cgi/content/full/jcb.200703010/DC1). As shown in Fig. 1 A, 
tyrosine phosphor  ylation of multiple proteins in a total membrane 
fraction was sharply down-regulated in confl  uent wild-type 
MEFs but not in confl  uent Nf2
−/− MEFs. Upon serum depriva-
tion, phosphotyrosine (pTyr) levels declined in both confl  uent 
wild-type and Nf2
−/− membranes, indicating their dependence 
upon soluble growth factors (Fig. 1 A, right). Thus, in prolifer-
ating wild-type MEFs, serum growth factors maintain a physio-
logical level of tyrosine kinase activity that is down-regulated as 
Figure 1.  Persistent EGFR signaling in multi-
ple types of conﬂ  uent Nf2 
−/− cells. (A) Tyrosine-
phosphorylated proteins in total membrane 
preparations from MEFs at increasing stages 
of conﬂ   uence. At early conﬂ   uence (*) in the 
presence of serum, wild-type (top) and Nf2
−/− 
(bottom) cells display a similar pattern of pTyr; 
(see Fig. S2 for the deﬁ  nition of conﬂ  uence). 
Progression to late conﬂ  uence is accompanied 
by marked down-regulation of tyrosine kinase 
activity in wild-type, but not Nf2
−/− cells (left). 
In contrast, both wild-type and Nf2
−/− cells 
can down-regulate membrane pTyr after se-
rum starvation (right). Actin = loading control. 
(B) EGFR activation, detected with an antibody 
against phosphorylated Y845, parallels the 
pTyr content observed in response to increasing 
conﬂ  uence and serum starvation. In wild-type 
MEFs, pEGFR levels decrease as conﬂ  uence 
progresses, but remain high in Nf2
−/− cells 
in a serum-dependent manner. (C) Phosphor-
ylation of multiple EGFR tyrosine residues is 
down-regulated in wild-type late-conﬂ  uent 
primary MEFs and OBs grown in serum, but 
persist in the absence of Merlin. (D) Mem-
branes of conﬂ  uent Nf2
−/− LDCs display high 
pEGFR levels that are markedly reduced upon 
adenoviral reintroduction of Nf2
wt, but not mu-
tant Nf2
L64P. Nf2
L64P is underrepresented in the 
membrane fraction, but comparable to that of 
Nf2
wt in the total cell extract (tce). (E) Persistent 
activation of multiple EGFR targets is evident 
in membrane extracts from conﬂ  uent  Nf2
−/− 
cells compared with wild-type. Phosphorylated 
active forms are indicated by the letter “p” 
preceding the name of the protein. All experi-
ments were performed at least three times.MERLIN INHIBITS EGFR SIGNALING • CURTO ET AL. 895
confl  uence progresses; this down-regulation is  defective in the 
absence of Merlin.
Genetic cooperativity has been demonstrated between NF2 
and EGFR pathway mutations in Drosophila (LaJeunesse et al., 
2001). Moreover, the EGFR localizes to cell junctions, regulates 
cell adhesion, and can be negatively modulated by cadherin-
dependent cell contact (Hoschuetzky et al., 1994; Takahashi and 
Suzuki, 1996; Pece and Gutkind, 2000; Betson et al., 2002; Qian 
et al., 2004). However, the basis of coordination between cell–cell 
contact and EGFR activity is not known. Given the prominent 
pTyr-containing protein of 170 kD (the molecular weight of 
EGFR) apparent in confl  uent Nf2
−/− membranes (Fig. 1 A), we 
used antibodies against active, phosphorylated EGFR (pEGFR) 
to monitor EGFR activation in confl  uent wild-type and Nf2
−/− 
cells. We found that the steady-state levels of active EGFR also 
diminished with increasing cell density in membranes of wild-type 
MEFs but persisted in Nf2
−/− MEFs (Fig. 1 B).
To determine whether EGFR deregulation is a general 
signature of Nf2 defi  ciency, we examined EGFR activation in 
confl  uent primary osteoblasts (OBs) and liver-derived epithelial 
cells (LDCs), two key targets of Nf2-associated tumorigenesis in 
mice (McClatchey et al., 1998; Giovannini et al., 2000). Neither 
Nf2
−/− OBs nor LDCs undergo contact-dependent inhibition of 
proliferation (Fig S2 B; see Fig. 6). Like MEFs, wild-type OBs 
down-regulate membrane pTyr and pEGFR at high cell density 
in the presence of serum, whereas Nf2
−/− OBs maintain elevated 
levels of both (Fig. 1 C; not depicted). Similarly, confl  uent 
Nf2
−/− LDCs retain high levels of pEGFR (Fig. 1 D). Reintro-
duction of wild-type Nf2 (Nf2
wt) into Nf2
−/− MEFs, OBs, and 
LDCs restores contact-dependent inhibition of proliferation, 
electrondense AJs, and low levels of both pTyr and pEGFR (Fig. 
1 D, Fig. 2 B; Fig. S2 C; not depicted). In contrast, a version of 
Merlin containing a patient-derived missense mutation (Nf2
L64P) 
fails to stably localize to AJs (Lallemand et al., 2003; Fig. 3 C), 
inhibit proliferation, or reduce pEGFR levels (Fig. 1 D). Multiple 
tyrosine residues on the EGFR and multiple EGFR targets remain 
phosphorylated in confl  uent Nf2
−/− cells, suggesting that a 
program of EGFR signaling fails to be down-regulated (Gschwind 
et al., 2004) (Fig. 1, C and E). These data indicate that a continuous 
physiological activation of the EGFR persists in the membranes 
of confl  uent Nf2
−/− cells; this is consistent with the fact that they 
do not proliferate faster than wild-type cells, but proliferate 
continuously despite reaching confl  uence. Thus, three different 
cell types all fail to undergo contact-dependent inhibition of 
proliferation and to down-regulate EGFR signaling at high cell 
density in the absence of Merlin.
Merlin controls the activity and membrane 
distribution of EGFR upon cell–cell contact
To understand how Merlin normally controls EGFR activity, we 
examined EGFR signaling as wild-type cells reach high density. 
Confl  uent epithelial cells of breast and kidney origin become 
unresponsive to stimulation by EGF and other growth factors via 
a cadherin-dependent mechanism (Takahashi and Suzuki, 1996; 
Qian et al., 2004). Accordingly, we found that while acute EGF 
stimulation of confl  uent Nf2-expressing cells does induce tyro-
sine phosphorylation of the receptor itself, activation of EGFR 
effectors such as Src and Raf does not increase, suggesting that 
signal propagation from the activated EGFR is prevented once 
wild-type cells reach high cell density (Fig. 2 A). In contrast, 
stimulation of confl  uent Nf2
−/− cells results in a slight increase 
in the already elevated membrane phosphotyrosine content 
(Fig. 2 A). Reintroduction of Nf2
wt but not Nf2
L64P restored 
the block of EGFR signaling at high cell density (Fig. 2 B). 
Merlin does not appear to be a general  inhibitor of RTK activation 
because signaling from the IGF-I receptor, including its ability 
Figure 2.  Merlin prevents EGFR signaling in conﬂ  uent cells. (A) In late-
conﬂ  uent (L) wild-type MEFs, EGF-induced pTyr is limited to the EGFR with-
out concomitant activation of EGFR downstream effectors such as Src and 
Raf. Increased membrane pTyr is already present in late-conﬂ  uent Nf2
−/− 
MEFs. The response to IGF-I is not prevented by Merlin. (EGF: 40 ng/ml, 
30 min; IGF-I: 100 ng/ml, 30 min) (E = early conﬂ  uence; co = loading 
controls). (B) Reintroduction of Nf2
wt but not Nf2
L64P abrogates persistent 
membrane pTyr in late-conﬂ  uent Nf2
−/− MEFs; as in wild-type MEFs, EGF 
stimulation of Nf2
wt-expressing MEFs affects pTyr of only the EGFR itself. 
(C) Surface EGFR turnover in late-conﬂ  uent OBs. Conﬂ  uent wild-type and 
Nf2
−/− OBs were surface biotinylated at 4°C for 1 h and then shifted to 
37°C in the presence of serum. At the indicated time points, the amount of 
biotinylated EGFR remaining in the cell was evaluated in both the total bio-
tinylated fraction and in EGFR immunoprecipitates. Compared with wild-
type OBs (top panels), Nf2
−/− OBs (bottom panels) show accelerated 
clearing of surface-biotinylated EGFR. All experiments were performed at 
least three times.JCB • VOLUME 177 • NUMBER 5 • 2007  896
to transactivate the EGFR (Roudabush et al., 2000), occurs in 
confl  uent MEFs regardless of the Nf2 status (Fig. 2 A).
Induced phosphorylation of EGFR without activation of 
downstream targets in confl  uent, Nf2-expressing cells suggested 
that in this context the ability of the activated receptor to acquire 
signaling competence might be physically restricted by Merlin 
at cell confl  uence. Because Merlin is membrane associated and 
internalization of liganded EGFR is intimately linked to its signal-
ing output (Sorkin and Von Zastrow, 2002), we asked whether the 
absence of Merlin had any effect on the surface levels of EGFR. 
We biotin-labeled cell surface proteins in confl  uent wild-type 
and Nf2
−/− OBs. Although major differences in the levels of 
surface EGFR were not detected in wild-type and Nf2-expressing 
cells, clearance of EGFR was more rapid in confl  uent Nf2
−/− 
cells, consistent with an increased rate of activation and inter-
nalization (Fig. 2 C).
Merlin prevents EGFR internalization and 
effector association in contacting cells
To further explore the role of Merlin in EGFR membrane 
 localization we used Texas red–conjugated EGF (Tr-EGF) to 
visually track the EGFR in the presence and absence of Merlin. 
For these experiments we chose to use epithelial LDCs that are 
amenable to immunofl  uorescence localization analyses. In con-
fl  uent Nf2
−/− LDCs we found that within 30 min after stimula-
tion Tr-EGF localizes to intracellular vesicles in virtually every 
cell, consistent with ligand-activated EGFR internalization 
(Fig. 3 A and Fig. S3 A, available at http://www.jcb.org/cgi/
content/full/jcb.200703010/DC1). We then generated mosaic 
cultures to compare Nf2
−/− LDCs to neighboring cells into 
which Nf2
wt or Nf2
L64P were reintroduced. Tr-EGF internaliza-
tion was prevented by expression of Nf2
wt that, like EGFR, is 
enriched at cell–cell boundaries (Fig. 3 B and Fig. S3 B), but 
Figure 3.  Control of EGFR internalization and signaling by Merlin is contact dependent. (A–F) Internalization of ﬂ  uorescent Tr-EGF (2 μg/ml, 30 min) in 
conﬂ  uent LDCs. (green = Merlin; red = Tr-EGF; blue = DAPI). (A) Tr-EGF containing vesicles are found within virtually every Nf2
−/− LDC cell. (B) Internal-
ized Tr-EGF is rarely observed in cells expressing wild-type Merlin. Dotted lines demarcate non-internalizing Nf2
wt-expressing cells. (C) Tr-EGF internaliza-
tion is not prevented in cells expressing Nf2
L64P or, (D) in cells that express Nf2
wt but are situated at the free edge of a scrape wound. In these cells, Tr-EGF 
internalization occurs along the free edge itself. (E and F) Disruption of intercellular adhesion by Ca
2+ depletion promotes Tr-EGF internalization in conﬂ  uent 
Nf2
wt-expressing LDCs. E = 10 min; F = 30 min after Tr-EGF addition. Bar, 10 μm. (G) Average percentage distribution of ligand-internalizing cells in rela-
tion to Merlin expression and cell density. 200 Nf2
wt or Nf2
L64P-expressing cells enclosed within a conﬂ  uent monolayer, or Nf2
wt cells situated at the free 
edges of nonconﬂ  uent cultures, were scored in each of four separate experiments. Cells with internalized Tr-EGF were designated as positive (error bars, ± SD). 
(H) Disruption of intercellular adhesion by Ca
2+-depletion restores EGFR signaling in Nf2
wt-expressing LDCs. EGF (40 ng/ml, 30 min) was added to starved 
LDCs after 30 min preincubation in EGTA/Ca
2+-free medium.MERLIN INHIBITS EGFR SIGNALING • CURTO ET AL. 897
not by Nf2
L64P, which is excluded from cell–cell boundaries 
(Fig. 3 C; Lallemand et al., 2003). An identical response was 
seen after basolateral exposure to Tr-EGF (not depicted). Inter-
nalization of fl  uorescent transferrin proceeded similarly in the 
presence or absence of Merlin (Fig. S3 C). Importantly, Nf2
wt 
did not prevent Tr-EGF internalization from the free edge of 
cells bordering a scrape wound or small colony (Fig. 3, D and G; 
not depicted), consistent with the hypothesis that Merlin limits 
EGFR internalization specifi  cally upon cell–cell contact. In 
fact, disruption of cadherin-based intercellular adhesion by 
EGTA/Ca
2+ depletion resulted in the appearance of internalized 
Tr-EGF (Fig. 3, E and F) and increased EGFR signaling in 
Nf2
wt-expressing cells (Fig. 3 H). Importantly, endogenous levels 
of Merlin also prevented EGFR internalization in similar mosaic 
cultures (Fig. S3 D).
These results suggest that upon cell contact Merlin func-
tions to physically restrict ligand-activated EGFR from signaling. 
This interpretation is supported by the altered distribution of 
pEGFR in fractionated Triton-insoluble membranes in the ab-
sence of Merlin (Fig. 4 A). Although EGF stimulation of 
confl  uent wild-type cells yields the appearance of pEGFR that 
is confi  ned to higher density fractions (II and III) that also 
contain Merlin, both pEGFR and Merlin are excluded from frac-
tion I (Fig. 4 A). In contrast, upon EGF stimulation of confl  uent 
Nf2
−/− cells, a substantial pool of pEGFR appears in the lowest 
density fraction (I; Fig. 4 A). These results suggest that the 
physical state of pEGFR is altered in the absence of Merlin. 
Merlin, EGFR, and AJ components are all normally enriched in 
the Triton-insoluble membrane fraction, a poorly defi  ned bio-
chemical compartment enriched in signaling molecules and 
cyto  skeletal components and variously referred to as detergent-
resistant membranes, lipid rafts, cholesterol-rich domains, etc. 
(Adams et al., 1996; Roepstorff et al., 2002; Lucero and Robbins, 
2004; Stickney et al., 2004). Notably, the membrane distribution 
of Rac and RhoGDI, two proteins implicated in Merlin func-
tion, is unaffected by the absence of Merlin; in fact, in contrast 
to a recent report (Okada et al., 2005), we do detect recruitment 
of Rac to detergent-resistant membranes in both the presence 
and absence of Merlin (Fig. 4 A; not depicted). Consistent with 
this interpretation, reintroduction of Nf2
wt but not Nf2
L64P alters 
the solubility of EGFR in confl  uent LDCs (Fig. S4 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200703010/DC1).
As shown in Figs. 1 and 2, the propagation of signaling 
from the activated EGFR to its downstream targets is blocked 
in confl  uent Nf2-expressing cells. Therefore, we asked whether 
Merlin directly interferes with the ability of ligand-activated 
EGFR to interact with its canonical signaling effectors. Consistent 
with established models of EGFR activation, EGF stimulation 
of confl  uent Nf2
−/− LDCs causes EGFR to interact with Cbl, 
Grb2, Sos, and PLCγ; however, these interactions do not occur 
in the presence of Merlin (Fig. 4 B). Reintroduction of Nf2
wt, 
but not Nf2
L64P, prevents EGFR association with its immediate 
effectors in response to EGF despite phosphorylation of the 
EGFR itself (Fig. 4 B); in fact, we do not detect changes in the 
responsiveness of EGFR to EGF ligand (Fig. S4 B). Impor-
tantly, under these conditions wild-type Merlin, but not Nf2
L64P, 
physically associates with the EGFR (Fig. 4 B). Altogether, 
these data suggest that Merlin prevents EGFR from interact-
ing with its immediate targets by sterically hindering the inter-
action and/or by sequestering the EGFR into a non-signaling 
membrane compartment from which both access to its down-
stream effectors and internalization are impeded. These data 
also indicate that Merlin acts at a step that precedes endocytosis 
of the activated EGFR. Indeed, EGF-induced Src activation and 
EGFR interaction with Grb2 and Cbl, early events that are re-
quired for EGFR internalization, do not occur in confl  uent Nf2-
expressing cells (Wilde et al., 1999; Stang et al., 2004; Johannessen 
et al., 2006).
The PDZ domain–containing adaptor 
NHE-RF1 mediates Merlin–EGFR association
NHE-RF1 is a PDZ domain–containing adaptor that interacts 
with Merlin and the ERM proteins (Reczek et al., 1997; Murthy 
et al., 1998; for review see Bretscher et al., 2002)  and is thought 
to play an important role in controlling the surface availability 
of certain membrane receptors including the β-adrenergic re-
ceptor and cystic fi  brosis transmembrane conductance regulator 
(for review see Weinman et al., 2006). Importantly, recent stud-
ies indicate that NHE-RF1 can also interact with and alter the 
surface availability of the EGFR (Lazar et al., 2004). This raises 
Figure 4.  Merlin controls EGFR membrane dis-
tribution and access to downstream effectors. 
(A) Optiprep gradient fractionation of Triton-
insoluble membranes from late-conﬂ  uent wild-
type and Nf2
−/− MEFs reveals altered physical 
distribution of pEGFR in Nf2
−/− cells after EGF 
stimulation (40 ng/ml, 30 min). In wild-type 
cells, pEGFR appears predominantly in fractions 
II and III, where Merlin is also present; both are 
excluded from the lowest density fraction I. In 
the absence of Merlin a unique pool of pEGFR 
appears in fraction I. In contrast, distribution of 
the small GTPase Rac is independent of Merlin 
status. (B) After reintroduction into Nf2
−/− LDCs, 
Nf2
wt but not Nf2
L64P complexes with EGFR 
and prevents its interaction with multiple signal-
ing effectors in re  sponse to EGF (40 ng/ml, 
10 min). Experimental conditions are as in Fig. 
1 D. All experiments were performed at least 
three times.JCB • VOLUME 177 • NUMBER 5 • 2007  898
the possibility that Merlin regulates the surface availability of 
EGFR via NHE-RF1. To determine whether NHE-RF1 medi-
ates the association between Merlin and EGFR, we performed 
shRNA-mediated knockdown of NHE-RF1 expression in Nf2
wt-
expressing LDCs. Lentiviral expression of a shRNA targeting 
NHE-RF1 revealed that reduced NHE-RF1 expression nearly 
eliminated the association of Nf2
wt and EGFR (Fig. 5 A). In 
contrast, Nf2
wt associates with Ezrin regardless of the level of 
NHE-RF1 expression (Fig. 5 B). Importantly, NHE-RF2 does 
not detectably associate with EGFR in these cells and shRNA-
mediated knockdown of NHE-RF2 expression has little effect 
on the association between Merlin and EGFR (Fig. 5 C; not 
depicted). These data suggest that Merlin–EGFR association is 
mediated specifi  cally by NHE-RF1.
Adhesion-dependent function of Merlin
Merlin localizes to AJs and is required for AJ stabilization 
(Lallemand et al., 2003). Our previous studies suggest that upon 
cell–cell contact, Merlin is recruited to and activated at nascent 
AJs; indeed, Merlin also associates with E-cadherin in epithe-
lial cells (Lallemand et al., 2003). The simplest interpretation of 
our data is that active, cadherin-associated Merlin “captures” 
the NHE-RF1–EGFR complex, thereby retaining it. Consistent 
with this hypothesis, we found that the association between 
EGFR and E-cadherin in confl  uent Nf2-expressing cells is 
NHE-RF1 dependent, whereas the association of Merlin with 
E-cadherin is NHE-RF1 independent (Fig. 5, A and D). A key 
prediction of this model is that the association between Merlin 
and both NHE-RF1 and EGFR is dependent on cell–cell contact; 
indeed, as shown in Fig. 5 (E and F), the association between 
Merlin and NHE-RF1 or EGFR is dramatically enhanced with in-
creasing cell density. In contrast, the association between EGFR 
and NHE-RF1 is not adhesion dependent (Fig S5 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200703010/DC1). 
Importantly, after acute disruption of intercellular contacts by 
Ca
2+ depletion, Merlin rapidly dissociates from EGFR (Fig. 5 F), 
indicating that cell–cell adhesion is a strict determinant for 
EGFR–Merlin association.
Pharmacological inhibition of EGFR inhibits 
proliferation of conﬂ  uent Nf2
−/− cells
To determine whether EGFR activation is responsible for the 
persistent tyrosine phosphorylation of membrane proteins and 
proliferation of confl  uent Nf2
−/− cells, we treated Nf2
−/− MEFs, 
OBs, and LDCs with pharmacologic EGFR inhibitors. Both 
Compound 56 and Gefi  tinib (Iressa), potent specifi  c inhibitors 
of EGFR kinase activity (Gschwind et al., 2004), eliminated 
the high membrane pTyr content in confl  uent Nf2
−/− cells of 
all three cell types in the presence of serum  (Fig. 6 A; not 
 depicted).  The  specifi  city of each compound was demonstrated by 
its ability to block EGF- but not PDGF-induced membrane pTyr 
(Fig. 6 A; not depicted). Importantly, before confl  uence, EGFR 
inhibitors had only a modest effect on the proliferation of pri-
mary Nf2
−/− MEFs, OBs, and LDCs in the presence of serum 
Figure 5.  NHE-RF1–mediated, contact-dependent asso-
ciation of Merlin and EGFR. (A) Immunoprecipitation of 
EGFR from total membrane extracts of Nf2
wt-expressing 
LDCs with and without lentiviral NHE-RF1 shRNA expres-
sion revealed that the association of both Nf2
wt and 
E-cadherin with the EGFR are nearly eliminated by NHE-
RF1 knockdown. (B) Immunoprecipitation of Ezrin reveals 
that the association of Nf2
wt with Ezrin occurs in a NHE-
RF1–independent manner. (C) NHE-RF2 knockdown does 
not affect EGFR-Merlin association. (D) The association 
between Nf2
wt and E-cadherin is not affected by NHE-RF1 
down-regulation. (E) Immunoprecipitation of NHE-RF1 
from total membrane extracts of subconﬂ  uent (s) and con-
ﬂ  uent (c) Nf2
wt-expressing LDCs revealed that the associa-
tion between Nf2
wt and NHE-RF1 occurs only in conﬂ  uent 
conditions. Total IgG is shown as a control for the NHE-
RF1 immunoprecipitations. (F) Immunoprecipitation of EGFR 
from total membrane extracts of Nf2
wt-expressing LDCs 
when sparse (s), conﬂ  uent (c), and after cell–cell contact 
disruption by incubation in Ca
2+-depleted medium for 
45 min (d). Complexing of Merlin and EGFR markedly 
increases from sparse to conﬂ  uent cells and is abrogated 
by acute loss of intercellular contacts. All experiments were 
performed at least three times.MERLIN INHIBITS EGFR SIGNALING • CURTO ET AL. 899
(Fig. 6, B and C; not depicted), indicating that proliferation of 
non-contacting cells can be sustained by serum-derived signals 
other than those mediated by EGFR. However, EGFR inhibition 
halted proliferation at high cell density; thus, Nf2
−/− cells can 
undergo contact-dependent inhibition of proliferation if EGFR 
activity is blocked. As shown in Fig. 6 D, EGFR inhibition did 
not restore permanent contact-dependent inhibition of prolifera-
tion to Nf2
−/− cells because withdrawal of the inhibitor led to re-
entry into the proliferative state despite the high cell density. These 
results suggest that EGFR inhibitors, already in clinical use for 
several human cancers, could also be of therapeutic benefi  t for 
NF2-defi  cient tumors. In fact, EGFR inhibitors may actually be 
more effi  cacious in preventing the physiologic EGFR activation 
that persists in confl  uent Nf2
−/− cells rather than the high levels 
driven by oncogenic EGFR mutations. Notably, signaling via 
EGFR family members (ErbBs) is critical for the proliferation 
and survival of Schwann cells, the principle target of NF2-
associated tumorigenesis in humans (Garratt et al., 2000).
Discussion
The discovery, in 1993, that the NF2 tumor suppressor, Merlin, is 
a member of a family of membrane/cytoskeleton-associated 
proteins suggested a novel mechanism of tumor suppression 
(Rouleau et al., 1993; Trofatter et al., 1993). Amidst the identifi  -
cation of many Merlin-interacting proteins and Merlin-controlled 
activities, a clear role for Merlin in controlling contact-dependent 
inhibition of proliferation has emerged (Morrison et al., 2001; 
Johnson et al., 2002; Lallemand et al., 2003). Loss of contact-
dependent inhibition of proliferation is a signature of cell trans-
formation, but the molecular basis of this phenomenon is not 
known. Our previous work identifi  ed a role for Merlin in stabi-
lizing AJs between cells, but did not pinpoint the mitogenic sig-
nal that drives proliferation in the absence of Merlin and normal 
AJs (Lallemand et al., 2003). An intimate relationship between 
RTK activity and AJ stability clearly exists, but its molecular un-
derpinnings are only beginning to emerge (for review see Brunton 
et al., 2004). We have now found that Merlin directly interferes 
with EGFR signaling in a contact-dependent manner, providing 
key insight into the molecular basis of contact-dependent inhibi-
tion of proliferation and directly linking the functions of a novel 
tumor suppressor and a well-known oncogene.
The aberrant cell–cell communication and persistent 
EGFR signaling in confl  uent Nf2
−/− cells, together with the 
localization of EGFR to AJs, suggests that Merlin normally co-
ordinates the processes of AJ stabilization and negative regula-
tion of the EGFR by establishing their interdependence as they 
occur. Our data are consistent with a model wherein the following 
sequence of events occurs (Fig. 7 A): Merlin is recruited to 
nascent AJs (Lallemand et al., 2003) where it is activated and 
begins to stabilize the developing junctions and sequester a pool 
of EGFR into a compartment from which it does not have 
access to its immediate downstream targets and cannot be inter-
nalized. Whether Merlin is in an “open” or “closed” conformation 
at this stage remains to be established; although many studies 
suggest that “active” Merlin is not phosphorylated at serine 518, 
it is not clear whether this hypophosphorylated form of Merlin 
is consistently self-associated. The ensuing localized reduction 
of EGFR tyrosine kinase activity at contact sites, in turn, may 
further stabilize AJs, perhaps via altering the phosphorylation 
of AJ components such as p120 (see Fig. 1 E) and/or the activity 
of Rac. Indeed, while initial stages of AJ formation are accom-
panied by increased tyrosine kinase activity and activation of 
the small GTPase Rac, a classic target of EGFR signaling that 
mediates dynamic membrane/cytoskeletal remodelling at cell–
cell interfaces (Pece and Gutkind, 2000; Betson et al., 2002; 
Goodwin et al., 2003), later stages are often associated with nega-
tive regulation of both EGFR and Rac (Brunton et al., 2004). 
This could explain previously reported roles for Merlin in nega-
tively regulating both Rac and its effector Pak and in modu-
lating actin cytoskeleton remodelling (James et al., 2001; Shaw 
et al., 2001; Kissil et al., 2003; Manchanda et al., 2005). Al-
though the precise mechanism whereby Merlin associates with 
the actin cytoskeleton is not yet clear, we have found that as-
sociation with the cortical actin cytoskeleton is necessary for 
the growth-suppressing and EGFR-inhibiting activities of Merlin 
(Cole, B.K., personal communication).
Molecularly, our studies indicate that Merlin directly links 
the AJ and EGFR. Indeed, the trilobed structure of the four-
point-one, ERM (FERM) domain appears well-designed for as-
sembling multiple proteins (Pearson et al., 2000). We found that 
the association between Merlin and EGFR is mediated by the 
tandem PDZ domain–containing adaptor NHE-RF1, which is 
known to interact with the third lobe of the ERM FERM domain 
Figure 6.  Pharmacological inhibitors of EGFR arrest proliferation of 
Nf2 
−/− cells. (A) Tyrosine phosphorylation of membrane proteins in late-
conﬂ  uent Nf2
−/− MEFs is eliminated by the EGFR inhibitor Compound 56. 
In the presence of the inhibitor (added 2 h before EGF addition), pTyr in-
duction is blocked after stimulation with EGF (40 ng/ml) but not PDGF 
(35 ng/ml) for 30 min. Similar speciﬁ  city was observed for Geﬁ  tinib (not 
depicted). Proliferation of Nf2
−/− OBs (B) and LDCs (C) at high cell density 
is inhibited by Geﬁ  nitib. (D) Inhibition of EGFR by Geﬁ  tinib does not per-
manently restore contact inhibition of growth in LDCs. All experiments were 
performed at least three times. (Error bars, ± SD).JCB • VOLUME 177 • NUMBER 5 • 2007  900
(Finnerty et al., 2004; Terawaki et al., 2006). NHE-RF1 can as-
sociate with and is thought to regulate the surface abundance of 
several different receptors (for review see Weinman et al., 2006). 
In fact, it has been reported that NHE-RF1 stabilizes and slows 
the down-regulation of surface EGFR (Lazar et al., 2004); how-
ever, neither this nor other studies have explored how functional 
specifi  city is applied to such a wide range of receptor interac  tions, 
and it is not clear how temporal and spatial regulation of NHE-
RF1–associated receptors is achieved. Our studies suggest that 
Merlin confers one such level of specifi  city by locally engaging 
NHE-RF1–associated EGFR at the AJ.
The ERM proteins also interact with NHE-RF1 and are 
required for stable apical localization of NHE-RF1 in the in-
testinal epithelium (Saotome et al., 2004). However, the ERM 
proteins likely engage a distinct subset of NHE-RF–associated 
receptors. Consistent with the tendencies of the ERM proteins 
and Merlin to be apically or apical-junctionally concentrated, 
respectively, the ERM proteins appear to be functionally dedi-
cated to the apical membrane and Merlin to the junctional 
domain (Fig. 7 B). By analogy to the roles of Merlin in both 
stabilizing the association between adhesion proteins and the 
actin cytoskeleton and locally “capturing” NHE-RF1–EGFR 
complexes, Ezrin may stabilize the association between the 
apical membrane and cortical cytoskeleton while capturing 
apical NHE-RF receptor complexes (Fig. 7 B). Indeed, Ezrin is 
required for establishing or maintaining the integrity of the 
apical surface of intestinal epithelial cells in vivo (Saotome 
et al., 2004). In contrast to Merlin, Ezrin does not associate with 
EGFR or E-cadherin, mediate contact-dependent inhibition of 
proliferation, or effect EGFR internalization/signaling in the cells 
studied here (Fig. S5 B), and overproliferation is not detected in 
the ERM-defi  cient intestine (Saotome et al., 2004).
It is clear that AJs are continuously remodelled both in 
confl  uent monolayers in culture and in tissues in vivo. In vivo, 
Figure 7.  Molecular and spatial attributes of Merlin function. (A) Model depicting the mechanism of Merlin-mediated coordination of AJ stabilization and 
EGFR down-regulation. In non-contacting cells (1), Merlin does not associate with cadherin or EGFR; however, upon cell–cell contact (2), Merlin is recruited 
to nascent junctions and activated, stabilizing the interaction between junctional proteins and the cortical cytoskeleton. Activated Merlin then “captures” 
NHE-RF1-associated EGFR (3), preventing it from internalizing or signaling. Active Merlin is likely hypophosphorylated and could be in an “open” or 
“closed” (self-associated) conformation; indeed, more than two conformational states of Merlin may exist. Although Merlin lacks the C-terminal actin-binding 
domain present in the ERM proteins, some studies suggest that Merlin can interact directly with ﬁ  lamentous actin via the FERM domain. Despite an 
abundance of evidence linking Merlin physically and functionally to the actin cytoskeleton, the precise mechanism whereby Merlin associates with the actin 
cytoskeleton remains unclear. (B) Although Merlin and the ERM proteins can all interact with NHE-RF1 and NHE-RF1 can, in turn, interact with several mem-
brane receptors, Merlin may be functionally dedicated to the junctional domain and the ERM proteins to the apical domain. In this way, spatial and temporal 
regulation of NHE-RF1–associated receptors may be achieved.MERLIN INHIBITS EGFR SIGNALING • CURTO ET AL. 901
all cells in solid tissues are in contact and junctional remodel-
ing and cell proliferation must be exquisitely coordinated. 
  Localization to intercellular adhesions may render the EGFR 
uniquely able to sense and modulate changes in cell contact 
and to fi  ne-tune its activity accordingly. Our molecular model 
of Merlin-mediated coordination of AJ stabilization and EGFR 
down-  regulation provides ample opportunity for fl  exibility. For 
example, phosphor  ylation or phospholipid binding may alter 
Merlin self-association and/or membrane distribution, coordinately 
affecting junction stability and EGFR signaling. Indeed, both 
hypo- and hyperphos  phorylated forms of Merlin are associated 
with EGFR (Fig. 4 B, Fig. 5 A), suggesting that S518 phos-
phorylation may regulate Merlin-associated EGFRs. We found 
that the association of Merlin with E-cadherin and with NHE-
RF1–EGFR are both contact dependent; however, it is interest-
ing to note that while the association of Merlin with E-cadherin 
and NHE-RF1 is maintained after acute disruption of inter-
cellular contacts (not depicted), the association between Merlin 
and EGFR is rapidly lost, suggesting disengagement of NHE-
RF1–EGFR in this specifi  c context. Our studies also indicate 
that the status of cell–cell contact has profound implications 
for the propagation of EGFR signaling. Conversely, in the context 
of EGFR-driven tumorigenesis, a critical line of investigation 
will be to determine whether oncogenic variants of the EGFR 
can evade the contact-dependent inhibition of signaling imposed 
by Merlin.
Pharmacologic EGFR inhibition abolished the persistent 
tyrosine phosphorylation of membrane proteins and the prolif-
eration of three types of Nf2
−/− cells in the presence of serum, 
suggesting that EGFR activation is necessary and suffi  cient to 
cause these phenotypes. This also suggests a novel avenue of 
therapeutic exploration for NF2. However, given that NHE-RF1 
can associate with multiple receptors, Merlin may well affect 
other receptors by a similar mechanism. In fact, the results pre-
sented here are complementary to those of Maitra et al. (2006), 
who reported altered surface availability of EGFR and other 
membrane receptors in Drosophila tissues lacking both Merlin 
and the related tumor suppressor, Expanded. Similarly, Merlin 
could coordinate regulation of EGFR or other receptors with alter-
native adhesion receptors such as CD44; it has been proposed 
that Merlin mediates contact-dependent inhibition of prolifera-
tion via CD44 in other cell types (Morrison et al., 2001). Indeed, 
the theme of Merlin-mediated coordination of cell adhesion 
and membrane receptor signaling is echoed by recent work in 
Drosophila suggesting that Merlin inhibits signaling through the 
Hippo/Warts/Yorkie pathway (Huang et al., 2005; Hamaratoglu 
et al., 2006), corresponding to the conserved Mst/Lats/Yap path-
way in mammals. Activation of this pathway in response to 
extracellular signals appears to be coordinately regulated by 
Merlin and Expanded, which signals from the Fat cadherin re-
ceptor (Bennett and Harvey, 2006; Silva et al., 2006; Willecke 
et al., 2006). However, neither the source of that extracellular 
signal nor the signaling receptor(s) involved have been identifi  ed 
in mammals or fl  ies (Edgar, 2006). The data presented here in-
dicate that Merlin could regulate signaling through this pathway 
by directly coordinating EGFR signaling output with cadherin-
dependent intercellular adhesion.
Materials and methods
Cell culture and expression vectors
Wild-type and Nf2
−/− primary MEFs were prepared as described previ-
ously (Lallemand et al., 2003). Wild-type primary OBs were prepared from 
calvaria of Nf2
ﬂ  ox2/ﬂ  ox2 newborn mice as described previously (Ducy and 
Karsenty, 1995). Nf2 deletion in OBs was achieved via adenoviral expression 
of the Cre-recombinase as we described for MEFs (Lallemand et al., 2003). 
Primary MEFs and OBs were used between passages 3 and 6. Epithelial 
Nf2
−/− LDCs were derived by liver-speciﬁ  c, deletion of Nf2 in vivo by crossing 
Nf2
ﬂ  ox2/ﬂ  ox2 mice to transgenic Alb-Cre mice (Postic et al., 1999) (B6.Cg-
Tg(Alb-cre)21Mgn/J; Jackson Laboratories). In brief, the liver of a 12-wk-old 
Alb-Cre;Nf2
ﬂ  ox2/ﬂ  ox2 mouse was removed, minced, dissociated in Liver Disso-
ciation Medium (Invitrogen), and cultured in 10% FBS-DME. Wild-type epi-
thelial embryonic liver cells were derived from the liver of a day-14.5 
Nf2
ﬂ  ox2/ﬂ  ox2 embryo as described by Strick-Marchand and Weiss (2002), 
and subsequently adapted to the standard growth conditions used for all 
other cell lines. Clonal cell lines were established by limiting dilution. The 
generation and use of adenoviral vectors expressing Nf2
wt and Nf2
L64P 
have been described previously (Lallemand et al., 2003).
Antibodies
Primary antibodies against the following antigens were from Upstate Bio-
technology (active-β-catenin: ABC, 05–665, 1:1,000 dilution); Transduction 
Laboratories (pTyr: RC20, 610023; β-catenin: 610153; E-cadherin: 
610182; p120ctn: 610133; p120ctn-pY228: 612536; Caveolin-pY14: 
611338; c-Cbl: 610441; Grb2: 610111; Sos1: 610095; PLCγ: 610027; 
Rac1: 612652; all at 1:1,000 or 2,000 dilution); Santa Cruz Biotechnol-
ogy, Inc. (Merlin: sc331, 1:40,000 dilution; EGFR: sc1005); Cell Signaling 
(EGFR-pY845: 2231; EGFR-pY992: 2235; EGFR-pY1068: 2234; STAT3-
pY705: 9131; STAT5-pY694: 9351; Shc-pY239/240: 2434; MAPK-
pT202/Y204: 5120; AKT-pS473: 9271; Raf-pS259: 9421, all at 1:1,000 
dilution); Biosource International (Src: 44–656; Src-pY418: 44–660, used 
at 1:1,000); Abcam (EBP50/NHERF-I: ab3452); NeoMarker (EGFR: Ab17; 
Ezrin: Ab1); Sigma-Aldrich (actin: A-2547). Monoclonal anti-Merlin 1C4 
(a gift of Vijaya Ramesh, Massachusetts General Hospital, Boston, MA) was 
used at 1:1,000. Polyclonal anti-NHE-RF2 (B70; gift of Anthony Bretscher, 
Cornell University, Ithaca, NY) was used at 1:1,000. HRP-conjugated 
secondary antibodies to rabbit, mouse, or rat were from GE Healthcare.
Subcellular fractionation and Western blot analysis
Equal protein amounts of total cell and membrane extracts were analyzed 
by Western blot as described previously (Lallemand et al., 2003) with one 
modiﬁ  cation: the membrane pellet was directly solubilized in RIPA buffer 
containing 0.5% SDS. For density-gradient separation, postnuclear membrane 
pellets from three 150-mm dishes of late conﬂ  uent MEFs were lysed on ice 
for 30 min in Triton-lysis buffer (1% Triton X-100, 50 mM Tris-HCl, pH 7.4, 
150 mM NaCl, 1 mM EDTA, 1 mM EGTA, and 10 mM β-glycerophosphate 
plus protease and phosphatase inhibitors), resuspended in buffer A 
(250 mM sucrose, 1 mM EDTA, 20 mM tricine, and 1% Triton X-100 
and inhibitors) containing 35% Optiprep, sequentially overlayed with 25, 
15, 5, and 0% Optiprep-buffer A and centrifuged for 3.5 h at 160000 g. 
Fractions collected at the interfaces I = 0–5%, II = 5–15%, III = 15–25%, 
IV = 25–35%, and the pellet V > 35%, were resuspended in RIPA buffer 
and analyzed (7 μg/lane) by immunoblotting.
Immunoﬂ  uorescence and ligand-internalization assay
LDCs plated on glass coverslips were infected with Ad.Nf2
wt or Ad.Nf2
L64P 
when  50% conﬂ   uent. After 4–5 d, conﬂ   uent monolayers were serum 
starved in 1% BSA in DME for 2 h, incubated for 30 min at 37°C with 
2 μg/ml Tr-EGF (E3480; Molecular Probes) or 10 μg/ml Alexa Fluor 
488-Transferrin (T13342; Molecular Probes), and ﬁ  xed in 4% PFA-cytoskeletal 
buffer (10 mM MES, pH 6.3, 2 mM EGTA, 3 mM MgCl2, and 138 mM 
KCl) for 15 min at room temperature. After permeabilization in 0.2% Triton 
X-100, cells were incubated with primary anti-NF2 antibody (sc331; 
1:300 in 1% BSA-PBS) overnight at 4°C. After incubation with FITC- or 
rhodamine-conjugated anti–rabbit secondary antibody (Jackson Immuno-
research Laboratories; 1:200), coverslips were mounted with Vectashield 
(Vector Laboratories). To create noncontacting free edges in Ad.Nf2
wt-infected 
LDCs, monolayers growing in 10% FBS-DME were scrape-wounded with a 
pipet tip, allowed to recover for  6 h, and starved (2 h) before adding 
Tr-EGF as described above. To disrupt intercellular adhesion by depletion 
of extracellular Ca
2+, monolayers were serum starved for 2 h, washed 
twice in Ca
2+-free DME (Invitrogen), incubated in 2 μg/ml Tr-EGF, 1% 
BSA, and 5 mM EGTA in Ca
2+-free DME and ﬁ  xed as above at the indicated JCB • VOLUME 177 • NUMBER 5 • 2007  902
time points. Images were acquired using a 63× 1.4NA oil objective lens 
(Carl Zeiss MicroImaging, Inc.) on an Axioplan microscope (Carl Zeiss 
MicroImaging, Inc.) with IP Lab software and a Sony CCD camera. Final 
images were prepared using Adobe Photoshop 7.0.
Surface biotinylation and immunoprecipitation
Late conﬂ  uent MEFs or OBs were serum starved overnight in DME, shifted to 
4°C, rinsed twice in cold PBS and incubated for 1 h with 0.5 μg/ml EZ-Link 
Sulfo-NHS-LC-Biotin (Pierce Chemical Co.) in PBS. After quenching the re  action 
(50 mM NH4Cl, 1 mM MgCl2, and 0.1 mM CaCl2 for 10 min) and rinsing 
in PBS, cells were returned to 10% FBS-DME at 37°C and lysed in Triton-lysis 
buffer containing 60 mM Octylglucoside (n-Octyl-β-D-glucopyranoside; 
Calbiochem) at the indicated time points. Normalized extracts (600 μg 
total protein/400 μl) were precleared with protein A–Sepharose prebound 
to normal rabbit IgG for 2 h at 4°C. Anti-EGFR antibody (Ab17, Neo-
Marker; 8 μg/sample) or streptavidin-coupled agarose beads (50 μl; 
Pierce Chemical Co.) were added to precleared extracts and incubated 
overnight at 4°C. The following day, EGFR-containing immunocomplexes 
were precipitated with protein A–Sepharose beads (40 μl, 2 h, at 4°C). 
Beads from either immunoprecipitation or biotin pull-down were washed 
ﬁ  ve times in the above buffer and boiled 5 min in 2× sample buffer. Com-
plexes were separated by 8% SDS-PAGE and analyzed by Western blot as 
described above. Biotinylated-immunoprecipitated EGFR was detected with 
HRP-conjugated streptavidin. Immunoprecipitations of EGFR (Ab17; 8 μg) 
and E-cadherin (3 μg) from LDCs were from total membrane extracts in the 
above Triton-Octylglucoside buffer (800 μg total protein/400 μl). To disrupt 
intercellular adhesion by depletion of extracellular Ca
2+, conﬂ  uent monolayers 
were washed twice in PBS/5 mM EGTA, and incubated in Ca
2+-free DME 
(Invitrogen) containing 10% Ca
2+-chelated FBS for 45 min.
Cell proliferation
MEFs, OBs (5 × 10
4) or LDCs (7.5 × 10
4) were seeded in triplicate 15-mm 
wells in 5% FBS-DME. The following day, 1 μM Geﬁ  tinib (Iressa; AstraZeneca) 
or 0.5 μM Compound 56 (Calbiochem) were added to culture wells; cells 
were trypsinized and counted every other day. Fresh medium with or with-
out inhibitors was added each day of counting. For drug withdrawal, 1 μM 
Geﬁ  tinib was added to LDCs daily until day 5 post-seeding, when half of 
the wells were returned to 5% FBS-DME only. Beginning that day, cells were 
counted and fresh medium with or without inhibitor was added to the re-
maining wells every other day.
shRNA-mediated knockdown
Several shRNA constructs against NHE-RF1 (#68583-68587) and NHE-
RF2 (#68613-68615, 68617) in the lentiviral pLKO.1 vector were ob-
tained from Open Biosystems and tested for NHE-RF1/2 knockdown in 
Nf2
−/− LDCs; #68587 and #68617 were used for experiments. Lentiviral 
production and infection was performed as described previously (Bailey 
et al., 2006).
Online supplemental material
Fig. S1 shows level and distribution of adhesion molecules in various cell 
types used in this work. Fig. S2 deﬁ  nes conﬂ  uence states in mesenchymal 
cells and shows transmission electron micrographs that reveal restoration 
of electrondense AJs upon expression of Nf2
wt in LDCs. Fig. S3 shows in-
ternalization of ﬂ  uorescent EGF and transferrin in LDCs, EGFR localization 
in LDCs, and inhibition of ﬂ  uorescent EGF internalization in conﬂ  uent em-
bryonic liver cells expressing endogenous Nf2. Fig. S4 shows decreased 
EGFR solubility in the presence of Merlin and a similar dose dependency of 
EGFR auto-phosphorylation in the presence or absence of Merlin. Fig. S5 
shows that the association of endogenous EGFR and NHE-RF1 is contact 
independent and reveals the lack of association between Ezrin and EGFR 
or Ezrin and E-cadherin in LDCs. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200703010/DC1.
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